Caricamento quotazioni...
Previsioni
Il prezzo obiettivo medio degli analisti è 57,94 € (+2053,90%). La mediana è 36,99 € (+1275,09%).
| Acquista |
4 |
| Mantieni |
14 |
| Vendi |
2 |
Notizie Vai al feed delle notizie
Tilray Brands (ex Aphria) raises quarterly revenue to USD 257.2 million (+22.7%)
Tilray Brands (ex Aphria) reported for the quarter ended August 31, 2026 a revenue increase of 22.74% to USD 257.2 million, compared with USD 209.5 million a year earlier. The earnings figure was released on October 8, 2026. » Altro su finanzen.net
Tilray invests £50m in BrewDog to improve beers, pubs and working conditions
Tilray, which bought BrewDog in March for £33m after the brewer entered administration, is investing more than £50m to improve beer quality, reopen and upgrade selected bars, raise pay and improve working conditions. The company is upgrading the Aberdeenshire brewery, launching new beers, introducing US craft lines into BrewDog venues and considering further UK craft acquisitions. Administrators said creditors will not be repaid in full and crowdfunding shares were rendered worthless, though some investor benefits and supplier continuity have been maintained. » Altro su theguardian.com
Tilray positioned to benefit if Trump advances marijuana rescheduling
A federal appeals court refused to pause the Biden administration's move to consider broader rescheduling of marijuana, keeping alive a proposal to reclassify cannabis to Schedule III. Schedule III would not legalize recreational use or interstate commerce but could ease research and expand medical opportunities that would help Tilray's international medical cannabis business. Tilray reported record fiscal 2026 revenue, sharply improved cash flow and near-elimination of net debt, and management sees U.S. rescheduling as a future growth opportunity. Legal challenges and timing remain uncertain, so potential investors should view rescheduling as upside rather than a guaranteed catalyst. » Altro su finance.yahoo.com
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | agosto 2026 | YoY |
|---|---|---|
| Ricavi | 221,35 Mln | 23,51% |
| Utile lordo | 66,72 Mln | 35,72% |
| Utile netto | -37,13 Mln | 13.382,06% |
| EBITDA | -11,35 Mln | 161,77% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 291,05 Mln € |
Numero di azioni | 111,83 Mln |
Massimo/minimo a 52 settimane | 13,99 € - 2,59 € |
| Dividendi | No |
Beta | 1,92 |
Rapporto P/E | -2,09 |
Rapporto PEG | -0,02 |
Rapporto P/B | 0,24 |
Rapporto P/S | 0,34 |
Profilo aziendale
Tilray Brands Inc. beschäftigt sich mit der Forschung, dem Anbau, der Produktion, dem Marketing und dem Vertrieb von medizinischen Cannabisprodukten. Das Unternehmen ist in fünf Segmenten tätig: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, und Business Under Development. Das Unternehmen bietet medizinische und für Erwachsene bestimmte Cannabisprodukte, pharmazeutische und Wellness-Produkte, alkoholische Getränke sowie hanfbasierte Lebensmittel und andere Wellness-Produkte an. Es bietet seine Produkte Einzelhändlern, Großhändlern, Patienten, Ärzten, Apotheken, Kliniken, Krankenhäusern, Regierungen und Forschern an. Das Unternehmen betreibt Tilray Medical, eine medizinische Plattform, die GMP-zertifizierte Blüten, Öle, Vapes, Esswaren und topische Produkte anbietet. Es hat Niederlassungen in Kanada, den Vereinigten Staaten, Europa, Australien, Neuseeland, Lateinamerika und international. Das Unternehmen war früher unter dem Namen Tilray, Inc. bekannt. Tilray Brands Inc. wurde im Jahr 2018 gegründet und hat seinen Hauptsitz in New York, New York.
| Nome | Tilray |
| CEO | Irwin David Simon |
| Sede centrale | Leamington,
on Stati Uniti |
| Sito web | |
| Settore | Sanità |
| Industria | Biotecnologia |
| Quotazione in borsa | 19/07/2018 |
| Dipendenti | 3595 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
NASDAQ | TLRY |
Toronto Stock Exchange | TLRY.TO |
XETRA | 2HQ.DE |
Frankfurt | 2HQ.F |
Düsseldorf | 2HQ.DU |
Hamburg | 2HQ.HM |
SIX | 2HQ.SW |
München | 2HQ.MU |
Wien | TLRY.VI |